CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Regeneron Pharmaceuticals, Inc. - REGN CFD

982.13
0.36%
Market Trading Hours* (UTC) Opens on Tuesday at 13:30

Tue - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
Trading сonditions
Spread 3.60
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 980.45
Open 980.2
1-Year Change 30.89%
Day's Range 980.2 - 994.06
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
May 24, 2024 983.96 -0.18 -0.02% 984.14 994.95 978.03
May 23, 2024 980.45 0.71 0.07% 979.74 991.17 973.21
May 22, 2024 980.47 -9.48 -0.96% 989.95 996.51 980.03
May 21, 2024 993.88 11.93 1.21% 981.95 995.23 981.95
May 20, 2024 987.02 10.86 1.11% 976.16 987.76 974.17
May 17, 2024 981.91 23.48 2.45% 958.43 982.36 958.43
May 16, 2024 967.29 -4.64 -0.48% 971.93 977.42 964.97
May 15, 2024 977.36 -1.46 -0.15% 978.82 987.95 963.01
May 14, 2024 981.81 10.76 1.11% 971.05 987.35 967.02
May 13, 2024 976.90 10.65 1.10% 966.25 981.35 966.25
May 10, 2024 972.68 13.87 1.45% 958.81 978.67 958.81
May 9, 2024 966.50 14.49 1.52% 952.01 969.71 948.76
May 8, 2024 955.11 -12.62 -1.30% 967.73 968.38 949.42
May 7, 2024 969.80 14.03 1.47% 955.77 970.18 954.55
May 6, 2024 957.47 2.52 0.26% 954.95 961.15 947.43
May 3, 2024 956.78 31.79 3.44% 924.99 957.13 924.99
May 2, 2024 937.15 39.57 4.41% 897.58 943.51 889.95
May 1, 2024 900.33 12.80 1.44% 887.53 912.79 886.63
Apr 30, 2024 890.56 5.67 0.64% 884.89 896.45 883.67
Apr 29, 2024 891.72 10.52 1.19% 881.20 896.68 881.20

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Regeneron Company profile

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema (DME); myopic choroidal neovascularization; and diabetic retinopathy in patients with DME, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. It also provides Dupixent injection to treat adult patients with moderate-to-severe atopic dermatitis; Praluent injection, an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease; and Kevzara solution for subcutaneous injection to treat rheumatoid arthritis in adults. In addition, the company offers ARCALYST injection for cryopyrin-associated periodic syndromes; and ZALTRAP, an injection for intravenous infusion, which is used in combination with 5-fluorouracil, leucovorin, and irinotecan for the treatment of metastatic colorectal cancer. Further, it develops EYLEA, a trap-based clinical product that is in Phase III study for the treatment of neovascular glaucoma; and Dupixent, Praluent, Kevzara, Suptavumab, Cemiplimab, Fasinumab, Evinacumab, Nesvacumab/aflibercept, Trevogrumab, REGN1908-1909, REGN1979, REGN3470-3471-3479, REGN2477, REGN3500, REGN3767, and REGN3918, which are antibody-based clinical programs under various stages of development. The company has collaboration and license agreements with Sanofi, Bayer, Mitsubishi Tanabe Pharma, Teva, Intellia Therapeutics, Adicet Bio, Decibel Therapeutics, Astellas, Alnylam Pharmaceuticals, Inc., and others. Regeneron Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Tarrytown, New York.
Industry: Bio Therapeutic Drugs

777 Old Saw Mill River Road
TARRYTOWN
NEW YORK 10591
US

News

Copper price slumps as traders take profits, where to next?

Copper price drops over 5% on Thursday as traders take profits following the FOMC meeting minutes.

16:17, 24 May 2024

Market analysis: EUR/GBP driven by diverging policy expectations

The EURGBP is driven by the question: which cuts first, the ECB or the BOE? Currently, swaps markets (chart below) imply that it will be the ECB (blue line).

13:46, 24 May 2024

UK CPI Preview: Will inflation return to 2% as the BoE predicts? And how will it affect GBP?

The latest round of inflation data will be released at 22 April at 7 am BST and investors are likely going to be paying close attention.

15:44, 21 May 2024

Reserve Bank of New Zealand Preview: RBNZ could become more dovish as inflation eases and growth softens

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, May 22, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

15:29, 21 May 2024

Nvidia Q1 Earnings Preview: Analysts forecast another blockbuster set of results

Nvidia (NVDA) reports its Q1 results after the closing bell on Wednesday, May 22nd. We preview what to expect from Nvidia’s earnings and analyse its stock's technicals.

14:57, 21 May 2024
CPI, consumer price index symbol.

Disinflation resumes in the US as CPI drops in April

The rate of growth in US consumer prices dropped in April leading markets to price in more chances of rate cuts from the Fed

11:24, 16 May 2024

Stock market crash: how far can the S&P 500 go?

After a remarkably strong first quarter, the US stock market pulled back in April for the first time since October last year.

11:46, 10 May 2024

People also watch

Oil - Crude

77.92 Price
+0.250% 1D Chg, %
Long position overnight fee 0.0075%
Short position overnight fee -0.0294%
Overnight fee time 21:00 (UTC)
Spread 0.040

BTC/USD

68,560.25 Price
-0.240% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

US100

18,811.60 Price
+0.010% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

XRP/USD

0.53 Price
-0.310% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading